Skip to content

Opko Health OPK Accounts Receivable

Accounts Receivable at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$1.59B+13.0%
HRO
HarrowHROW
$101.26M+31.4%
Precigen logo
PrecigenPGEN
$26.4M+3,416%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$121M+22.4%
Abbott logo
AbbottABT
$8.21B+12.1%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$44.01M-108%

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's accounts receivable?
Opko Health (OPK) reported accounts receivable of $79.64M in Q1 2026.
How has Opko Health's accounts receivable changed year-over-year?
Opko Health's accounts receivable decreased by 17.2% year-over-year, from $96.15M to $79.64M.
What is the long-term trend for Opko Health's accounts receivable?
Over 5 years (2020 to 2025), Opko Health's accounts receivable has grown at a 104.9% compound annual growth rate (CAGR), from $2.5M to $90.26M.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.